# A Study of Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic Pouchitis

> **NCT04799496** · — · COMPLETED · sponsor: **Takeda** · enrollment: 688 (actual)

## Conditions studied

- Inflammatory Bowel Diseases
- Colitis, Ulcerative
- Crohn Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04799496
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-10
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 688 (ACTUAL)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04799496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04799496, "A Study of Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic Pouchitis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04799496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*